A Phase 1, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Radavirsen (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 30 Jun 2016 Status changed from active, no longer recruiting to completed.
- 30 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 04 Aug 2015 Planned primary completion date changed from 1 Dec 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov record.